Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Compression Wear on Muscle Soreness (COMDOME)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03417323
Recruitment Status : Completed
First Posted : January 31, 2018
Last Update Posted : July 6, 2018
Sponsor:
Collaborator:
German Sport University, Cologne
Information provided by (Responsible Party):
University of Erlangen-Nürnberg Medical School

Brief Summary:

The study address two main topics:

  1. The effect of compression garment on whole-body electromyostimulation (WB-EMS) induced muscle soreness in young adults
  2. The repeated bout effect of one intense session of WB-EMS as determined by various regeneration parameters

Condition or disease Intervention/treatment Phase
Muscular Regeneration Repeated Bout Effect of WB-EMS Other: Compression Not Applicable

Detailed Description:
Using a cross-over design we applied 2 intense WB-EMS training sessions either with or without subsequent wearing of compression garments (long tights) for 5 days at baseline and after a washout period of 4 weeks. Healthy young to middle aged athletes used compression garments immediately postexercise for 24 hours and further 12 h during the day. Blood samples, questionnaires, resting metabolic rate and performance test were applied prior and 24, 48,72 and 96 h post-exercise consistently without wearing compression garments.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 23 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Double (Care Provider, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of Compression Wear on Whole-body Electromyostimulation and Exercise-induced Muscle Soreness. A Randomized Controlled Trial.
Actual Study Start Date : December 10, 2017
Actual Primary Completion Date : February 22, 2018
Actual Study Completion Date : May 31, 2018

Arm Intervention/treatment
Experimental: Compressive garment
Groups wear compression garment after WB-EMS induced muscle soreness
Other: Compression
Participants in the treatment group wear compression garment after intense WB-EMS application for 24 h, and 12 h for day 2, 3, 4 post WB-EMS.

No Intervention: No compression garment
Groups wear no compression garment after WB-EMS induced muscle soreness



Primary Outcome Measures :
  1. Maximum isokinetic leg extensor strength [ Time Frame: 5 days ]
    Changes of isokinetic leg extensor strength during the intervention period


Secondary Outcome Measures :
  1. Perceived physical state [ Time Frame: 5 days ]
    Changes of perceived physical state as determined by the WKV-scale (Kleinert, 2001) during the intervention period

  2. Resting metabolic rate [ Time Frame: 5 days ]
    Changes of resting metabolic rate during the intervention period

  3. Myoglobin [ Time Frame: 5 days ]
    Changes of myoglobin-levels during the intervention period

  4. Heart rate variability [ Time Frame: 5 days ]
    Changes of Heart rate variability during the intervention period

  5. creatine-kinase (CK) concentration [ Time Frame: 5 days ]
    Changes of CK-levels during the intervention period



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   25 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • healthy athletes with >5 years of experience in competition balls sports and corresponding discipline specific resistance exercise

Exclusion Criteria:

  • diseases and medication affecting muscle metabolism
  • contraindication for WB-EMS

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03417323


Locations
Layout table for location information
Germany
Institute of Medical Physics University of Erlangen-Nurnberg
Erlangen, Germany, 91052
Institute of Medical Physics, University of Erlangen-Nurnberg
Erlangen, Germany, 91052
Sponsors and Collaborators
University of Erlangen-Nürnberg Medical School
German Sport University, Cologne
Investigators
Layout table for investigator information
Study Chair: Helmut Lötzerich, PhD German Sport University, Cologne
Principal Investigator: Wolfgang Kemmler, PhD University of Erlangen-Nürnberg Medical School
Additional Information:
Publications:
Layout table for additonal information
Responsible Party: University of Erlangen-Nürnberg Medical School
ClinicalTrials.gov Identifier: NCT03417323    
Other Study ID Numbers: Compression_DOMS_EMS
First Posted: January 31, 2018    Key Record Dates
Last Update Posted: July 6, 2018
Last Verified: July 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Myalgia
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Nervous System Diseases
Musculoskeletal Pain
Pain
Neurologic Manifestations
Signs and Symptoms